BPC-157 & TB-500 & GHK-Cu Blend "GLOW"

BPC-157 is described as a synthetic peptide composed of fifteen amino acids and is believed to originate from a fragment of a gastric-derived protein, although the exact source protein has not yet been definitively identified. Research models suggest that BPC-157 may interact with intracellular signalling systems involved in vascular development through angiogenic pathways, as well as influence inflammatory processes by modulating pro-inflammatory signalling mechanisms.(1)

TB-500 is a synthetic peptide that mirrors the 43-amino-acid structure of the naturally occurring thymosin beta-4. It has been studied for its role in cellular migration, cytoskeletal organisation, and inflammatory signalling. In vitro research indicates that TB-500 exposure may support cellular movement and structural coordination, while also participating in pathways associated with angiogenesis and the regulation of inflammatory mediators.(2)

GHK-Cu is a peptide complex formed from the tripeptide GHK—comprising glycine, histidine, and lysine—bound to a divalent copper ion (Cu²⁺). It is suggested that the GHK sequence occurs naturally within the body and may be released by cells such as fibroblasts, macrophages, and lymphocytes in response to tissue damage, particularly during collagen degradation.(3) As such, GHK-Cu is proposed to function as a signalling molecule for repair, interacting with enzymes, ion channels, and cell-surface receptors, with potential downstream effects on gene expression. The copper component is considered integral to these actions, particularly in relation to collagen synthesis, modulation of inflammatory responses, and antioxidant activity.

These peptides are thought to exhibit partially overlapping yet complementary mechanisms of action, supporting the hypothesis that their combined presence may influence inflammatory signalling in a beneficial manner. Collectively, they may also contribute to the regeneration of various cell types, potentially supporting processes such as vascular development and overall cellular function.

Chemical Makeup

Other Known Titles

  • BPC-157: C62H98N16O22
  • TB-500: C212H350N56O78S
  • GHK-Cu: C14H23CuN6O4

Molecular Weight:

  • BPC-157:5 g/mol
  • TB-500: 4963 g/mol
  • GHK-Cu: 38 g/mol

Molecular Formula:

  • BPC-157: Body Protection Compound-157
  • TB-500: Synthetic Thymosin Beta-4
  • GHK-Cu: glycyl-L-histidyl-L-lysine-copper 2+
Research and Clinical Studies
Anti-inflammatory Signaling Research on BPC-157 & TB-500 & GHK-Cu

All three peptides appear to exhibit partially overlapping yet complementary roles in the regulation of inflammatory signalling both within and between cells. Notably, each has been associated with potential effects in reducing or modulating inflammatory processes. For instance, laboratory research conducted by Santra et al. suggests that TB-500 may attenuate inflammation-related signalling in cultures of oligodendrocyte progenitor cells—cells involved in supporting brain development.(4) Following cellular stress or injury, these cells are thought to activate innate immune pathways, particularly Toll-like receptor (TLR) signalling, which may drive intracellular inflammatory responses.

The researchers explored whether TB-500 may reduce this signalling and proposed that the peptide could elevate levels of miR-146a, a small regulatory RNA molecule believed to function as a suppressor of inflammatory pathways. Increased miR-146a levels may lead to a reduction in key TLR-associated proteins, IRAK1 and TRAF6, thereby limiting their ability to propagate inflammatory signals within the cell. This may include downstream pathways such as NF-κB activation, which plays a central role in inflammation signalling.

Further research by Sikiric et al. indicates that BPC-157 may also interact with inflammatory processes, particularly by reducing inflammatory cell infiltration in experimental models.(5) Observations included decreased levels of biochemical markers associated with inflammation, such as indicators of neutrophil accumulation, leukotriene B4, and thromboxane B2 in inflamed cellular environments. Additionally, BPC-157 appeared to influence immune cell behaviour, with reports suggesting increased macrophage activity that may support the resolution phase of inflammation rather than its persistence. Importantly, these effects were observed without direct suppression of specific cytokines such as TNF, suggesting a more regulatory mode of action. It has also been proposed that BPC-157 may interact with the nitric oxide (NO) system, potentially protecting endothelial function and indirectly limiting inflammatory amplification through preservation of microvascular integrity.

Finally, experiments conducted by Park et al. suggest that GHK-Cu may also contribute to the modulation of inflammatory signalling, particularly in macrophages activated by pro-inflammatory stimuli and in models of lung cell injury.(6) In activated macrophages, GHK-Cu was observed to reduce intracellular reactive oxygen species while restoring superoxide dismutase activity toward baseline levels. Pro-inflammatory triggers were associated with increased release of TNF-α and IL-6, whereas GHK-Cu appeared to reduce the levels of these cytokines. Mechanistically, the findings suggest that GHK-Cu may suppress NF-κB activation by influencing key regulatory components, although no significant effects were observed on ERK1/2, JNK1/2, or nitric oxide secretion. In lung cell models, the peptide complex was associated with reductions in oedema, inflammatory cell infiltration, and overall tissue injury scores. Additional observations included decreased TNF-α, IL-6, total cell counts, neutrophil presence, myeloperoxidase (MPO) activity, and markers of alveolar permeability.

Cellular Regeneration Potential of BPC-157 & TB-500 & GHK-Cu

In addition to their proposed roles in modulating inflammatory signalling, all three peptides have been suggested to support cellular regeneration through distinct yet complementary mechanisms that may enhance vascularisation and nutrient delivery to tissues. Notably, TB-500 has been associated with regenerative effects through its influence on cellular mobility, thereby supporting angiogenesis.

Research by Lv et al. indicates that TB-500 may interact with cell movement by binding to globular actin (G-actin), potentially influencing the assembly of actin filaments. This interaction may enable endothelial cells to alter their shape, migrate more effectively, and organise into multicellular structures.(7) Such motility is essential for sprouting angiogenesis, where endothelial cells migrate into hypoxic regions and form new vascular networks. The study further reported that TB-500 appeared to increase cell viability, migration, and tube formation in experimental models—commonly used as indicators of angiogenic activity. In parallel, elevated expression of angiogenesis-related factors such as VEGFA, angiopoietin-2 (Ang2), and the Tie2 receptor was observed. Mechanistically, it was proposed that TB-500 may promote angiogenesis via a Notch-to-NF-κB signalling axis, combining cytoskeletal modulation with pro-angiogenic signalling pathways to support vascular development in damaged tissues.

Research by Sikiric et al. suggests that BPC-157 may also contribute to angiogenesis and tissue regeneration, although through a slightly different mechanism.(8) Rather than directly stimulating vessel formation, BPC-157 may act by stabilising the vascular environment necessary for angiogenesis. Across various injury models, the peptide has been associated with protection of endothelial cells and preservation of vessel integrity, creating favourable conditions for endothelial sprouting and maturation. At the molecular level, BPC-157 has been linked to activation of repair-associated pathways, including Egr-1 and its regulator NAB2, as well as FAK–paxillin signalling, which are involved in cell adhesion and migration. These processes are critical for endothelial movement through the extracellular matrix during capillary formation. Additionally, BPC-157 has been associated with normalisation of nitric oxide (NO) signalling under both excessive and deficient conditions. Given the role of NO in vasodilation, endothelial survival, and angiogenesis, this regulatory effect may support blood flow, endothelial activation, and vascular remodelling during tissue repair.

Mechanistic insights from research by Mulder et al. suggest that GHK-Cu may also promote angiogenesis through multiple pathways.(9) The peptide complex has been associated with increased expression of VEGF, enhanced endothelial cell proliferation, and improved migration and tube formation—key processes in new blood vessel development. Furthermore, the copper component of GHK-Cu is recognised as an essential cofactor in several angiogenic enzymes and transcriptional pathways. The GHK peptide is thought to facilitate the delivery of copper in a biologically active form to sites of tissue damage, thereby supporting cellular repair and vascular growth.

Collagen Repair Potential of BPC-157 & TB-500 & GHK-Cu

Multiple experimental studies involving each of the three peptides suggest that they may support the regeneration and repair of collagen and other structural components within cell cultures, including tendon fibroblasts. For example, research by Xu et al. on TB-500 indicates that the peptide may contribute to improved structural organisation in models of recovering tendon tissue.(10) Observations included collagen fibres that were more uniformly aligned along the ligament axis and more evenly distributed compared to controls. Electron microscopy further revealed larger collagen fibril diameters, a characteristic associated with enhanced mechanical strength. These structural improvements were accompanied by increased tensile strength and stiffness in the repaired tendon tissue.

Based on these findings, researchers proposed that TB-500 may influence how ligament fibroblasts organise and deposit collagen during the repair process, thereby improving overall tissue quality. Similarly, BPC-157 has been associated with supporting tendon repair through its effects on fibroblast activity. Research by Chang suggests that the peptide may accelerate fibroblast migration and spreading in laboratory models—both critical processes for repopulating injured tissue. Additionally, BPC-157 appeared to enhance fibroblast survival under oxidative stress conditions, which are commonly present in damaged tissue environments.

At the cellular level, these effects have been linked to increased actin fibre formation, with researchers noting that “F-actin formation as detected by FITC-phalloidin staining was induced in BPC-157-exposed cells.” Furthermore, activation of focal adhesion signalling pathways—specifically through phosphorylation of FAK and paxillin—has been proposed to support cell attachment and movement within the extracellular matrix, ultimately facilitating tissue repair.

GHK-Cu has also been suggested to promote collagen synthesis, particularly at the interface between tendon and bone tissue. Research by Fu et al. indicates that models exposed to the peptide complex may demonstrate enhanced bone formation around tendon grafts, along with increased cellular presence within the graft structure itself. Collectively, these findings suggest that all three peptides may contribute to cellular repair and structural integrity through mechanisms such as anti-inflammatory signalling, angiogenesis, and collagen synthesis. However, it is important to note that no studies to date have evaluated the combined effects of all three peptides within a single experimental model.

BPC-157 & TB-500 & GHK-Cu blend is available for research and laboratory purposes only. Please speak to our friendly research team to find out more and for sourcing options.

References:

  1. Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Pretoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB, Sikiric P. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021 Jun 29;12:627533. doi: 10.3389/fphar.2021.627533. PMID: 34267654; PMCID: PMC8275860.

  2. Maar, K., Hetenyi, R., Maar, S., Faskerti, G., Hanna, D., Lippai, B., Takatsy, A., & Bock-Marquette, I. (2021). Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies. Cells, 10(6), 1343.  https://doi.org/10.3390/cells10061343

  3. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988 Oct 10;238(2):343-6. doi: 10.1016/0014-5793(88)80509-x. PMID: 3169264.

  4. Santra M, Zhang ZG, Yang J, Santra S, Santra S, Chopp M, Morris DC. Thymosin β4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway. J Biol Chem. 2014 Jul 11;289(28):19508-18. doi: 10.1074/jbc.M113.529966. Epub 2014 May 14. PMID: 24828499; PMCID: PMC4094061.

  5. Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Stambolija V, Zoricic Z, Vrcic H, Sebecic B. Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. Curr Med Chem. 2012;19(1):126-32. doi: 10.2174/092986712803414015. PMID: 22300085.

  6. Park JR, Lee H, Kim SI, Yang SR. The tripeptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget. 2016 Sep 6;7(36):58405-58417. doi: 10.18632/oncotarget.11168. PMID: 27517151; PMCID: PMC5295439.

  7. Lv S, Cai H, Xu Y, Dai J, Rong X, Zheng L. Thymosin-β 4 induces angiogenesis in critical limb ischemia mice via regulating Notch/NF-κB pathway. Int J Mol Med. 2020 Oct;46(4):1347-1358. doi: 10.3892/ijmm.2020.4701. Epub 2020 Aug 11. PMID: 32945357; PMCID: PMC7447324.

  8. Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zukanovic G, Crvenkovic D, Madzarac G, Rukavina I, Sucic M, Baric M, Starcevic N, Krstonijevic Z, Bencic ML, Filipcic I, Rokotov DS, Vlainic J. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865. doi: 10.2174/1570159x13666160502153022. PMID: 27138887; PMCID: PMC5333585.

  9. Mulder GD, Patt LM, Sanders L, Rosenstock J, Altman MI, Hanley ME, Duncan GW. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. 1994 Oct;2(4):259-69. doi: 10.1046/j.1524-475X.1994.20406.x. PMID: 17147644.

  10. Xu B, Yang M, Li Z, Zhang Y, Jiang Z, Guan S, Jiang D. Thymosin β4 enhances the healing of medial collateral ligament injury in rats. Regul Pept. 2013 Jun 10;184:1-5. doi: 10.1016/j.regpep.2013.03.026. Epub 2013 Mar 21. PMID: 23523891.

  11. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011 Mar;110(3):774-80. doi: 10.1152/japplphysiol.00945.2010. Epub 2010 Oct 28. PMID: 21030672.

  12. Fu SC, Cheuk YC, Chiu WY, Yung SH, Rolf CG, Chan KM. Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction. J Orthop Res. 2015 Jul;33(7):1024-33. doi: 10.1002/jor.22831. Epub 2015 Apr 10. PMID: 25731775.

Dr. Marinov

Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research.

BPC-157 & TB-500 & GHK-Cu Blend "GLOW"